Robert DiCenzo, Pharm.D., BCPS, FCCP



  • Antiretroviral Pharmacology and Pharmacometrics Fellowship, University at Buffalo
  • Pharm.D., Albany College of Pharmacy and Health Sciences 
  • B.S. in Pharmacy, University at Buffalo

Teaching Experience

  • Application of Drug Interaction Information in Clinical Practice
  • Applied Pharmacotherapy
  • Biopharmaceutics & Pharmacokinetics
  • Biostatistics in Pharmacy
  • Experimental Therapeutics
  • Pathophysiology and Therapeutics
  • Pharmacotherapeutics

Academic/Research Interests

Antiretroviral pharmacology and the influence of transporter proteins on the toxicokinetics of drugs of abuse.  Additional interests include increasing the pneumococcal vaccination rates of elderly Vermonters.

Honors and Achievements

  • 2015 APhA Academy of Pharmaceutic Research and Sciences President-elect
  • New York State Chapter of the American College of Clinical Pharmacy Researcher of the Year (2009)
  • Inducted as a Fellow in the American College of Clinical Pharmacy (2008)
  • American College of Clinical Pharmacy Hematology/Oncology Investigator Development Research Award for the project entitled “Optimizing Adjuvant Chemotherapy in obese and overweight women” (2005)
  • NYSCHP-Amgen Oncology Leadership Research Award for the project entitled “Optimal Breast Cancer Adjuvant Chemotherapy Dosing in Obese and Overweight Women” (2004)
  • Top Abstract Award at the ASCPT 103rd Annual Meeting as recognition for being first author on the poster entitled “Once Daily Dosing (ODD) Algorithm for Gentamicin (G) in Neonates (NEO)” (2002)

Selected Publications

DiCenzo, R, Ed (2011). Clinical Pharmacist’s Guide to Biostatistics and Literature Evaluation. Lenexa, KS: American College of Clinical Pharmacy.

 KK Janke, MH Nelson, AS Bzowyckyj, DG Fuentes, E Rosenberg, and R DiCenzo. Deliberate Integration of Student Leadership Development in Doctor of Pharmacy Programs. AJPE 2015 (Accepted for Publication: Ms. No. ajpe5211R1).

 ME Morris, BL Morse, GJ Baciewicz, MM Tessena, NM Acquisto, DJ Hutchinson and R DiCenzo. Monocarboxylate Transporter Inhibition with Osmotic Diuresis Increases γ-Hydroxybutyrate Renal Elimination in Humans: A Proof-of-Concept Study. J Clinic Toxicol 2011; 1(2): 1:104.

DiCenzo, R. (Ed.). (2011). Clinical Pharmacist’s Guide to Biostatistics and Literature Evaluation. Lenexa, KS: American College of Clinical Pharmacy, 2011.

R DiFrancesco, SL Rosenkranz, AL Mukherjee, LM Demeter, H Jiang, R DiCenzo, C Dykes, A Rinehart, M Albrecht, GD Morse. Quality Assessment for Therapeutic Drug Monitoring in AIDS Clinical Trials Group (ACTG 5146): A Multicenter Clinical Trial. Ther Drug Monit accepted for publication Apr 2010.

R DiCenzo, R DiFrancesco, K Cruttenden, J Donnely, G Schifitto. Lopinavir cerebrospinal fluid steady-state trough concentrations in HIV-infected adults. Ann Pharmacother 2009; 43:1972-1977. 

LM Demeter, H Jiang, AL Mukherjee, GD Morse, R DiFrancesco, R DiCenzo, C Dykes, P Sista, L Bacheler, K Klingman, A Rinehart, M Albrecht. A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patient. AIDS 2009; 23(3): 357-368.

R DiCenzo, DR Peterson, K Cruttenden, P Mariuz, NL Rezk, J Hochreiter, H Gelbard, G Schifitto. Effects of minocycline and valproic acid coadministration on atazanavir plasma concentrations in human immunodeficiency virus-infected adults receiving atazanavir-ritonavir. Antimicrobial Agents and Chemotherapy 2008; 52 (9):3035-39.

E. Thingvoll, R. Guillet, M. Caserta, R. DiCenzo. Observational trial of a 48-Hour gentamicin dosing regimen derived from monte carlo simulations in infants born <28 weeks' gestation. J Pediatr 2008; 153(4):530-534. 

YJ Moon, L Wang, R DiCenzo, ME Morris. Quercetin pharmacokinetics in humans. Biopharm Drug Dispos 2008; 29:205-217.

SM McCabe,Q Ma, JC Slish, LM Catanzaro, N Sheth, R DiCenzo, GD Morse. Pharmacokinetic Considerations in Patients with Renal or Hepatic Impairment. Clin Pharmacokinet 2008; 47 (3): 153-172. 

LM Demeter, L Mukherjee, R DiFrancesco, H Jiang, R DiCenzo, B Bastow, AR Rinehart, GD Morse, M Albrecht. The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-Infected patients. HIV Clin Trials 2008; 9(1):61-72.

R Constantinescu, M McDermott, R DiCenzo, EA de Blieck, CH Hyson, MF Beal, E Bednarczyk, M Bogdanov, LJ Metakis, SE Browne, BJ Lorenzo, B Ravina, K Kieburtz. A randomized study of the bioavailability of different formulations of coenzyme Q10 (Ubiquinone). Journal of Clin Pharm 2007; 47:1580-1586.

R DiFrancesco, R DiCenzo, G Vicente, J Donnelyy, TM Martin, LA Colon, G Schifitto and GD Morse. Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometry. J Pharm Biomed Anal 2007; 44(5):1139-46.

R DiFrancesco, J Griggs, J Donnelly and R DiCenzo. Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry. Journal of Chromatography B 2007; 852: 545-553. 

R. DiCenzo, A. Luque, P. Larppanichpoonphol, R. Reichman. Association of total bilirubin with indinavir and lopinavir plasma concentrations in HIV-infected patients receiving 3 different double boosted dosing regimens. J Antimicrob Chemother 2006; 58(2): 393-400. 

R. DiCenzo, V. Frerichs, P. Larppanichpoonphol, L. Predko, A. Chen, R. Reichman, M. Morris. Assessment of effect of quercetin on saquinavir plasma and intracellular concentrations in healthy adults. Pharmacotherapy 2006; 26(9): 1255-1261.

R. DiCenzo, A. Forrest, MA. Fischl, A. Collier, J. Feinberg, H. Ribaudo, R. DiFrancecso, GD. Morse, and the AIDS Clinical Trials Group 388/733/5060 Study Team. Pharmacokinetics of indinavir and nelfinavir in treatment-naïve, human immunodeficiency virus-infected subjects. Antimicrobial Agents and Chemotherapy 2004; 48(3):918-923.

R. DiCenzo, M. Shelton, K. Jordan, C. Koval, A. Forrest, R. Reichman, GD. Morse. Coadministration of milk thistle and indinavir in healthy subjects. Pharmacotherapy 2003; 23(7):866-870.

R. DiCenzo, A. Forrest, JC. Slish, C. Cole, R. Guillet. A gentamicin pharmacokinetic population model and once daily dosing algorithm for neonates. Pharmacotherapy 2003; 23(5):585-591.

R. DiCenzo, A. Forrest, KE. Squires, SM. Hammer, MA. Fischl, H. Wu, R. Cha, GD. Morse, and the Adult AIDS Clinical Trials Group Protocol 368/886 Study Team. Indinavir, efavirenz and abacavir pharmacokinetics in HIV-Infected subjects. Antimicrobial Agents and Chemotherapy 2003; 47(6):1929-1935.

Interim Dean of the
School of Pharmacy and Pharmaceutical Sciences;
Department of Pharmacy Practice